Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2015/2026)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
, Table of Contents
Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and and Antivirals
Ethical Considerations
Chapter 02: Pharmacokinetics,
Pharmacodynamics, and
Pharmacogenetics
Chapter 03: Cultural Considerations
Chapter 04: Complementary and
Alternative Therapies
Chapter 05: Pediatric Considerations
Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use
Disorder
Chapter 08: The Nursing Process and
Patient-Centered Care
Chapter 09: Safety and Quality
Chapter 10: Drug Administration
Chapter 11: Drug Calculations
Chapter 12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and Mineral
Replacement
Chapter 14: Nutritional Support
Chapter 15: Adrenergic Agonists and
Antagonists
Chapter 16: Cholinergic Agonists and
Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants
Chapter 19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and
Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular
Disorders and Muscle Spasms
Chapter 22: Antipsychotics and
Anxiolytics
Chapter 23: Antidepressants and Mood
Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
Chapter 27: Antituberculars, Antifungals,
,Anthelmintic
Chapter 29: HIV- and AIDS-
Related Drugs
Chapter 30: Transplant
Drugs Chapter 31:
Vaccines Chapter 32:
Anticancer Drugs
Chapter 33: Targeted Therapies to Treat
Cancer
Chapter 34: Biologic Response
Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear
Disorders Chapter 45:
Dermatologic Disorders Chapter
46: Pituitary, Thyroid,
Parathyroid, and Adrenal
Disorders Chapter 47:
Antidiabetics
Chapter 48: Urinary Disorders
Chapter 49: Pregnancy and
Preterm Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and
Newborn Chapter 52: Women's
Reproductive Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
, Table of Contents
Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and and Antivirals
Ethical Considerations
Chapter 02: Pharmacokinetics,
Pharmacodynamics, and
Pharmacogenetics
Chapter 03: Cultural Considerations
Chapter 04: Complementary and
Alternative Therapies
Chapter 05: Pediatric Considerations
Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use
Disorder
Chapter 08: The Nursing Process and
Patient-Centered Care
Chapter 09: Safety and Quality
Chapter 10: Drug Administration
Chapter 11: Drug Calculations
Chapter 12: Fluid Volume and
Electrolytes
Chapter 13: Vitamin and Mineral
Replacement
Chapter 14: Nutritional Support
Chapter 15: Adrenergic Agonists and
Antagonists
Chapter 16: Cholinergic Agonists and
Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants
Chapter 19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and
Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular
Disorders and Muscle Spasms
Chapter 22: Antipsychotics and
Anxiolytics
Chapter 23: Antidepressants and Mood
Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
Chapter 27: Antituberculars, Antifungals,
,Anthelmintic
Chapter 29: HIV- and AIDS-
Related Drugs
Chapter 30: Transplant
Drugs Chapter 31:
Vaccines Chapter 32:
Anticancer Drugs
Chapter 33: Targeted Therapies to Treat
Cancer
Chapter 34: Biologic Response
Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear
Disorders Chapter 45:
Dermatologic Disorders Chapter
46: Pituitary, Thyroid,
Parathyroid, and Adrenal
Disorders Chapter 47:
Antidiabetics
Chapter 48: Urinary Disorders
Chapter 49: Pregnancy and
Preterm Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and
Newborn Chapter 52: Women's
Reproductive Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic medication
may be given.The patient asks the nurse what this means. What will the nurse tell the patient
about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
a. is a controlled substance.
